Edible mushrooms: Novel medicinal agents to combat metabolic syndrome and associated diseases

研究成果: 雜誌貢獻回顧型文獻同行評審

7 引文 斯高帕斯(Scopus)


Metabolic syndrome is an aggregation of conditions and associated with an increased risk of develop-ing diabetes, obesity and cardiovascular diseases (CVD). Edible mushrooms are widely consumed in many coun-tries and are valuable components of the diet because of their attractive taste, aroma, and nutritional value. Medicinal mushrooms are higher fungi with additional nutraceutical attributes having low-fat content and a trans-isomer of unsaturated fatty acids along with high fiber content, biologically active compounds such as polysaccharides or polysaccharide β-glucans, alkaloids, steroids, polyphenols and terpenoids. In vitro experiments, ani-mal models, and even human studies have demonstrated not only fresh edible mushroom but also mushroom extract that has great therapeutic applications in human health as they possess many properties such as anti-obesity, cardioprotective and anti-diabetic effect. They are considered as the unmatched source of healthy foods and drugs. The focus of this report was to provide a concise and complete review of the novel medicinal properties of fresh or dry mushroom and extracts, fruiting body or mycelium and its extracts, fiber, polysaccharides, beta-glucan, triterpenes, fucoidan, ergothioneine from edible mushrooms that may help to prevent or treat metabolic syndrome and associated diseases.
頁(從 - 到)4970-4981
期刊Current Pharmaceutical Design
出版狀態已發佈 - 2020

ASJC Scopus subject areas

  • 藥理
  • 藥物發現


深入研究「Edible mushrooms: Novel medicinal agents to combat metabolic syndrome and associated diseases」主題。共同形成了獨特的指紋。